Observation unit treatment of heart failure with nesiritide: Results from the proaction trial

Journal of Emergency Medicine

Volumn 29, Issue 3, 2005, Pages 243-252

  Peacock IV, W F ^a   Holland, R ^b   Gyarmathy, R ^c   Dunbar, L ^d   Klapholz, M ^e   Horton, D P ^f   De Lissovoy, G ^g   Emerman, C L ^h  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SARASOTA MEMORIAL HOSPITAL   (United States)

^c Jacksonville Center for Clinical Research   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^e ST VINCENT S HOSPITAL   (United States)

^f SCIOS INC   (United States)

^g UNITED BIOSOURCE CORPORATION   (United States)

^h METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Decompensated heart failure; Emergency Department; Hospitalization; Length of stay; Nesiritide

Indexed keywords

NESIRITIDE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EMERGENCY WARD; FEMALE; HEADACHE; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; LEG CRAMP; LENGTH OF STAY; MALE; MULTICENTER STUDY; OBSERVATION; PATIENT; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS;

EID: 21044439337     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2005.01.024     Document Type: Article

References (20)

1. M.J. Hall, M.F. Owings 2000 National Hospital Discharge Survey Adv Data 19 2002 1 18
2. th Quarter 2002 National Database ADHERE 2003 Scios Inc Sunnyvale, CA
3. W.F. Peacock, C.L. Emerman, M.R. Costanzo, R.L. Borkowitz, M. Cheng Early initiation of intravenous therapy improves heart failure outcomes an analysis from the ADHERE registry database Ann Emerg Med 42 4 2003 S26
4. W.F. Peacock, E.E. Remer, J. Aponte, D.A. Moffa, C.E. Emerman, N.M. Albert Effective observation unit treatment of decompensated heart failure Congest Heart Fail 8 2002 68 73
5. C.L. Emerman, W.F. Peacock, G.C. Fonarow Effect of Emergency Department initiation of vasoactive infusion therapy on heart failure length of stay Ann Emerg Med 40 2002 S46
6. W.F. Peacock, J. Allegra, D. Ander Management of acute decompensated heart failure in the emergency department Congest Heart Fail Suppl 1 2003 3 18
7. Publication committee for the VMAC Investigators Intravenous nesiritide versus nitroglycerin for treatment of decompensated congestive HF the VMAC trial JAMA 287 2002 1531 1540
8. A.J. Burger, D.P. Horton, T. LeJemtel The effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive HF the PRECEDENT Study Am Heart J 144 2002 1102 1108
9. W.S. Colucci, U. Elkayam, D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure N Engl J Med 343 2000 246 253
10. A.J. Burger, U. Elkayam, M.T. Neibaur Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy Am J Cardiol 88 2001 35 39
11. W.F. Peacock, N.M. Albert Observation unit management of heart failure Emerg Med Clin North Am 19 2001 209 232
12. W.F. Peacock Heart failure management in the emergency department observation unit Prog Cardiovasc Dis 46 2004 465 485
13. U. Elkayam, M.W. Akhter, H. Singh Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure Am J Cardiol 93 2004 237 240
14. National Center for Health Statistics. National Hospital Discharge Survey, 1997. Available at: http://www.cdc.gov/nchs/about/major/hdasd/listpubs. htm. Accessed July 21, 2005.
15. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project: Nationwide Inpatient Sample, 1997. Available at: http://www.hcup-us.ahrg.gov/nisoverview.jsp. Accessed July 21, 2005.
16. M. Packer, J.N. Cohn Consensus recommendations for the management of chronic heart failure Am J Cardiol 83 1999 2A 1A-38A
17. Centers for Medicare and Medicaid Services. Medicare Provider Analysis and Review (MEDPAR) of Short-Stay Hospitals, 2001. Available at: http://www.cms.hhs.gov/statistics/medpar/. Accessed July 21, 2005
18. J. Bayliss, M. Norell, Canepa-Anson, G. Sutton, P. Poole-Wilson Untreated heart failure clinical and neuroendocrine effects of introducing diuretics Br Heart J 57 1987 17 22
19. S.S. Gottlieb, S.L. Skettino, A. Wolff Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure J Am Coll Cardiol 35 2000 56 59
20. M.R. Burger, A.J. Burger Nesiritide a promising new drug for the treatment of decompensated heart failure Heart 2 2002 39 46